IFNG and Alzheimer disease: Compared with the control group, the levels of IFN-γ in the serum of the AD group mice were significantly elevated, and after treatment with 10 and 15 mg/kg AZF, the expression levels of serum IFN-γ were reduced (Figure 3A).